Genetic Discovery Suggests Some Aspects of Childhood Leukemia Inherited

The discovery of a pair of genetic variants suggests that both susceptibility and survival of childhood leukemia can be inherited.

Investigators from London's Institute of Cancer Research, reporting in Blood, the journal of the American Society of Hematology, looked at the genomes of more than 1,500 children diagnosed with leukemia as well as those of 4,500 healthy children.

They found a strong link between two common DNA copying errors, known as single nucleotide polymorphisms (SNPs), and susceptibility to leukemia. One of the SNPs has been linked to higher rates of relapse and poorer outcomes, while the other has previously been linked to a difficult-to-treat subtype of the most common form of childhood leukemia, acute lymphoblastic leukemia (ALL).

Linking Genes to Treatment

While the cure rate, or five-year survival rate, for ALL hovers around 85 percent, there are still too many young patients who don't respond to the long-term, aggressive therapy established for the disease, and no consensus exists for treatment for this subset.

Said Chris Bunce, research director at Leukemia and Lymphoma Research, the organization funding the study:

These findings provide further insights into the genetic and biological basis of inherited genetic susceptibility to childhood acute lymphoblastic leukemia. By understanding how different genetic variations determine cancer subtype, we can tailor treatment accordingly.

These findings, coupled with other findings from the research institute in London as well as St. Jude's Children's Hospital in the US, give hope that soon new drugs and/or therapies will help all children with leukemia beat the disease.

Source: Blood

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap